Agonistic anti-CD40 antibodies in patients with solid tumors: a systematic review and evidence map...

TL;DR


Summary:
- This article provides a comprehensive overview of the role of the NLRP3 inflammasome in the pathogenesis of inflammatory diseases, detailing its activation mechanisms and regulatory pathways.
- It explores the therapeutic potential of targeting the NLRP3 inflammasome, highlighting recent advancements in small-molecule inhibitors and their clinical implications for treating autoimmune and autoinflammatory disorders.

Like summarized versions? Support us on Patreon!